{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000055","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.424792+00:00","generated_at":"2026-06-01T09:49:58.409233+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"GRI Bio receives Nasdaq delisting determination; plans to appeal by May 28, 2024","bullets":["Received Nasdaq Staff determination letter on May 21, 2024, for non-compliance with stockholders' equity rule (Rule 5550(b)) after initial 180-day cure period ended May 20, 2024.","Despite reporting >$2.5M equity as of March 31, 2024, Nasdaq considered historical burn rate and concluded non-compliance.","Company intends to request a hearing before a Nasdaq Hearings Panel by May 28, 2024, which will automatically stay suspension/delisting pending outcome.","Panel may grant up to 180-day extension, but no guarantee of regaining compliance or continued listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000055","json":"https://secwatch.observer/filing/0001824293-24-000055.json","markdown":"https://secwatch.observer/filing/0001824293-24-000055.md","text":"https://secwatch.observer/filing/0001824293-24-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000055/0001824293-24-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000055/val-20240521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:49:58.409233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}